|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o AFG Biosolutions Inc., formerly Advanced Biosystems Inc., of Germantown, Md., and Omnia Biologics Inc., of Rockville, Md., signed an agreement for Omnia to provide AFG with manufacturing and development services. AFG focuses on the research and development of a new generation of vaccines and immunotherapeutics for anthrax, plague, smallpox and tularemia.
o Alkermes Inc., of Cambridge, Mass., and Eli Lilly and Co., of Indianapolis, began a Phase III trial required for registration of their inhaled insulin system to treat diabetes. The study is designed to evaluate the safety and efficacy of the system compared to injected pre-meal insulin in 400 non-smoking ...